Researchers from Memorial Sloan kettering Cancer Center analyzed the top 20 infused cancer drugs dosed on body size and packaged in single-dose vials and found that drug manufacturers will earn almost $3 Billion from left over drugs. The researchers have proposed a requirement that manufacturers package drugs in quantities that allow for minimal wastage. Learn more here. (Source: Tracey Walker, Managed Healthcare Executive, 4/9/16)